A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(50 sites)

United States

Kirklin Clinic of UAB Hospital, Birmingham, Alabama

So Cal Institute for Respiratory Diseases, Inc., Los Angeles, California

University of California Davis Medical Center, Sacramento, California

National Jewish Health Main Campus, Denver, Colorado

MedStar Georgetown University Hospital, Washington D.C., District of Columbia